Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hohlfeld

Showing results (31-40 of 206) with videos related to

Pageof 21
Sort By:
Der Nervenarzt|December 1, 1992
[Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids]R Voltz, R Hohlfeld
Der Nervenarzt|June 1, 1994
[Current therapy of multiple sclerosis: "T-cell vaccination"]F Zipp, R Hohlfeld
MMW Fortschritte Der Medizin|June 10, 2009
[Update: treatment of multiple sclerosis]T Kümpfel, R Hohlfeld
Der Nervenarzt|February 1, 1992
[Current therapy of multiple sclerosis. Are there indications for plasmapheresis?]S Schönbeck, R Hohlfeld
Der Nervenarzt|February 1, 1996
[Current therapy of multiple sclerosis. Therapy with monoclonal antibodies to T-cell antigens (CD3, CD4, CD52)]S Schmidt, R Hohlfeld
Der Nervenarzt|July 21, 1999
['Fatigue' in multiple sclerosis]C Zimmermann, R Hohlfeld
Annals of Neurology|March 23, 2001
The ups and downs of multiple sclerosis therapeuticsR Hohlfeld, H Wiendl
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2003
Molecular pathogenesis of neuroinflammationM Bradl, R Hohlfeld
Neurology|June 1, 1995
Differential aspects of cytokines in the immunopathology of multiple sclerosisK Lucas, R Hohlfeld
Journal of Autoimmunity|August 1, 1990
T-cell mediated autoimmunity: molecular interactions and therapeutic implicationsC Linington, R Hohlfeld
Pageof 21

Showing results (31-40 of 206) with videos related to

Sort By:
Pageof 21
Der Nervenarzt|December 1, 1992
[Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids]R Voltz, R Hohlfeld
Der Nervenarzt|June 1, 1994
[Current therapy of multiple sclerosis: "T-cell vaccination"]F Zipp, R Hohlfeld
MMW Fortschritte Der Medizin|June 10, 2009
[Update: treatment of multiple sclerosis]T Kümpfel, R Hohlfeld
Der Nervenarzt|February 1, 1992
[Current therapy of multiple sclerosis. Are there indications for plasmapheresis?]S Schönbeck, R Hohlfeld
Der Nervenarzt|February 1, 1996
[Current therapy of multiple sclerosis. Therapy with monoclonal antibodies to T-cell antigens (CD3, CD4, CD52)]S Schmidt, R Hohlfeld
Der Nervenarzt|July 21, 1999
['Fatigue' in multiple sclerosis]C Zimmermann, R Hohlfeld
Annals of Neurology|March 23, 2001
The ups and downs of multiple sclerosis therapeuticsR Hohlfeld, H Wiendl
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2003
Molecular pathogenesis of neuroinflammationM Bradl, R Hohlfeld
Neurology|June 1, 1995
Differential aspects of cytokines in the immunopathology of multiple sclerosisK Lucas, R Hohlfeld
Journal of Autoimmunity|August 1, 1990
T-cell mediated autoimmunity: molecular interactions and therapeutic implicationsC Linington, R Hohlfeld
Pageof 21